High Risk Crack Use Settings and HIV in El Salvador (Encuentro)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01279421|
Recruitment Status : Active, not recruiting
First Posted : January 19, 2011
Last Update Posted : September 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|HIV Sexually Transmitted Diseases||Behavioral: Social Network HIV Testing Behavioral: Peer Network Intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4382 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||High Risk Crack Use Settings and HIV in El Salvador|
|Study Start Date :||November 2010|
|Actual Primary Completion Date :||June 2016|
|Estimated Study Completion Date :||October 2019|
Experimental: Social Network HIV Testing
Participants in this arm will be recruited through social networks and will receive an HIV test.
Behavioral: Social Network HIV Testing
Crack users will be recruited for HIV testing and receive 3 coupons to recruit other crack users for HIV testing.
Experimental: Peer Network Intervention
Eight (8) current or former crack users will be recruited to facilitate small networks of crack users in a three-day intervention. They will also facilitate monthly meetings open to all community members regarding HIV prevention and interpersonal violence.
Behavioral: Peer Network Intervention
Peer leaders will recruit small networks of crack users and facilitate a three-day prevention intervention.
- Increased HIV testing rates among crack users [ Time Frame: 24 months ]
- Decreased number of sexual risk behaviors among crack users [ Time Frame: 12 months ]
- Community and organizational factors associated with successful implementation of multi-level, community-based HIV prevention intervention [ Time Frame: 12 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01279421
|San Salvador, El Salvador|
|Principal Investigator:||Julia B. Dickson-Gomez, Ph.D.||Medical College of Wisconsin|
|Study Director:||Gloria Bodnar, Ph.D.||Fundacion Antidrogas de El Salvador (FUNDASALVA)|